Stable for approximately 28 days after reconstitution when stored properly and prepared with bacteriostatic water
A recent study found that the triple agonist retatrutide for GLP-1R, GIPR and GCGR substantially induced weight loss in obese adults, demonstrating the clinical potential of this triple agonist for obesity treatment
With the dual effect of "diabetes" and "weight loss", the development of GLP-1 long-acting receptor agonists has become a research hotspot at home and abroad
As a retatrutide research chemical, this compound serves as a documented triple-receptor agonist reference standard for GLP-1R, GIPR, and GCGR pathway studies
Combining tirzepatide microdosing with other longevity protocols Longevity-focused researchers frequently combine tirzepatide microdosing with other interventions
This is the most stable form for storage and shipping of peptide reference materials